Clinical Psychology and Psychiatry: A Closer Look

Psychiatric medications, science, marketing, psychiatry in general, and occasionally clinical psychology. Questioning the role of key opinion leaders and the use of "science" to promote commercial ends rather than the needs of people with mental health concerns.

Showing posts with label Invega. Show all posts
Showing posts with label Invega. Show all posts
Monday, November 05, 2007

Risperdal, er, Invega for Depression?

›
A new study (published in the Annals of Internal Medicine ) demonstrated that risperidone (Risperdal) was effective in reducing depressive ...
1 comment:
Friday, October 26, 2007

A Blog on Atypical Antipsychotics? SWEET!

›
I have discovered a blog (simply titled Atypical Antipsychotics ) that I believe has some serious potential. It has the following things I...
Tuesday, October 16, 2007

Invega: Just in the Nick of Time?

›
In a Bloomberg report , it was noted that: Johnson & Johnson cut costs as it faces generic competition to its best-selling prescription ...
6 comments:
Monday, October 15, 2007

Son of Risperdal Beats Seroquel

›
Janssen, manufacturer of Invega (son of Risperdal) funded a study comparing Invega, Seroquel, and placebo in the treatment of schizophrenia....
5 comments:
›
Home
View web version

About Me

CL Psych
I'm an academic with a respectable amount of clinical experience and no drug industry funding. Given my lack of time, don't expect multiple daily updates. Certain things about clinical psychology, the drug industry, psychiatry, and academics drive me nuts, and you'll probably pick up on these pet peeves before long...
View my complete profile
Powered by Blogger.